vs
INVO Fertility, Inc.（IVF）与Peraso Inc.（PRSO）财务数据对比。点击上方公司名可切换其他公司
Peraso Inc.的季度营收约是INVO Fertility, Inc.的1.6倍（$2.9M vs $1.8M），Peraso Inc.净利率更高（-43.3% vs -150.5%，领先107.2%），INVO Fertility, Inc.同比增速更快（22.6% vs -22.0%），过去两年INVO Fertility, Inc.的营收复合增速更高（12.8% vs 1.0%）
INVO Fertility是一家专注于辅助生殖医疗解决方案的企业，核心产品为专利INVOcell阴道内培养装置，服务北美、欧洲等地区的生殖诊所与患者，致力于降低生育治疗门槛，为有需求的群体提供可负担的生殖医疗服务。
Peraso Inc.是一家半导体技术企业，专注于设计和生产高性能毫米波（mmWave）集成电路与模块，为电信基础设施、工业物联网、固定无线接入及消费电子领域提供5G及下一代无线连接解决方案，服务全球多个地区的客户。
IVF vs PRSO — 直观对比
营收规模更大
PRSO
是对方的1.6倍
$1.8M
营收增速更快
IVF
高出44.6%
-22.0%
净利率更高
PRSO
高出107.2%
-150.5%
两年增速更快
IVF
近两年复合增速
1.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8M | $2.9M |
| 净利润 | $-2.6M | $-1.2M |
| 毛利率 | — | 52.2% |
| 营业利润率 | -93.1% | -44.6% |
| 净利率 | -150.5% | -43.3% |
| 营收同比 | 22.6% | -22.0% |
| 净利润同比 | -62.2% | 20.3% |
| 每股收益（稀释后） | $-0.77 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IVFPRSO
| Q4 25 | — | $2.9M | ||
| Q3 25 | $1.8M | $3.2M | ||
| Q2 25 | $1.9M | $2.2M | ||
| Q1 25 | $1.6M | $3.9M | ||
| Q4 24 | $1.7M | $3.7M | ||
| Q3 24 | $1.4M | $3.8M | ||
| Q2 24 | $1.8M | $4.2M | ||
| Q1 24 | $1.6M | $2.8M |
净利润IVFPRSO
| Q4 25 | — | $-1.2M | ||
| Q3 25 | $-2.6M | $-1.2M | ||
| Q2 25 | $-5.3M | $-1.8M | ||
| Q1 25 | $-17.4M | $-471.0K | ||
| Q4 24 | $-3.6M | $-1.6M | ||
| Q3 24 | $-1.6M | $-2.7M | ||
| Q2 24 | $-2.2M | $-4.4M | ||
| Q1 24 | $-1.6M | $-2.0M |
毛利率IVFPRSO
| Q4 25 | — | 52.2% | ||
| Q3 25 | — | 56.2% | ||
| Q2 25 | — | 48.3% | ||
| Q1 25 | 35.2% | 69.3% | ||
| Q4 24 | 41.4% | 56.3% | ||
| Q3 24 | 31.0% | 47.0% | ||
| Q2 24 | 53.1% | 55.5% | ||
| Q1 24 | 45.3% | 46.4% |
营业利润率IVFPRSO
| Q4 25 | — | -44.6% | ||
| Q3 25 | -93.1% | -36.8% | ||
| Q2 25 | -160.4% | -80.0% | ||
| Q1 25 | -1042.1% | -13.3% | ||
| Q4 24 | -202.0% | -44.3% | ||
| Q3 24 | -90.7% | -70.3% | ||
| Q2 24 | -100.9% | -105.6% | ||
| Q1 24 | -95.7% | -128.9% |
净利率IVFPRSO
| Q4 25 | — | -43.3% | ||
| Q3 25 | -150.5% | -37.4% | ||
| Q2 25 | -283.6% | -82.4% | ||
| Q1 25 | -1060.1% | -12.2% | ||
| Q4 24 | -211.3% | -42.4% | ||
| Q3 24 | -113.8% | -70.6% | ||
| Q2 24 | -122.2% | -104.4% | ||
| Q1 24 | -101.3% | -72.1% |
每股收益（稀释后）IVFPRSO
| Q4 25 | — | $-0.09 | ||
| Q3 25 | $-0.77 | $-0.17 | ||
| Q2 25 | $-13.30 | $-0.31 | ||
| Q1 25 | $-12.53 | $-0.10 | ||
| Q4 24 | $14.86 | $0.36 | ||
| Q3 24 | $-15.11 | $-0.98 | ||
| Q2 24 | $-22.39 | $-1.88 | ||
| Q1 24 | $-7.55 | $-1.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $2.9M |
| 总债务越低越好 | $2.0M | — |
| 股东权益账面价值 | $5.8M | $4.6M |
| 总资产 | $18.8M | $6.1M |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
现金及短期投资IVFPRSO
| Q4 25 | — | $2.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $1.9M | ||
| Q1 24 | — | $2.4M |
总债务IVFPRSO
| Q4 25 | — | — | ||
| Q3 25 | $2.0M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $7.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IVFPRSO
| Q4 25 | — | $4.6M | ||
| Q3 25 | $5.8M | $3.6M | ||
| Q2 25 | $2.6M | $3.0M | ||
| Q1 25 | $3.3M | $3.6M | ||
| Q4 24 | $12.7M | $3.5M | ||
| Q3 24 | $-23.3K | $2.0M | ||
| Q2 24 | $1.4M | $3.6M | ||
| Q1 24 | $10.2K | $6.7M |
总资产IVFPRSO
| Q4 25 | — | $6.1M | ||
| Q3 25 | $18.8M | $6.2M | ||
| Q2 25 | $19.3M | $5.5M | ||
| Q1 25 | $31.7M | $6.7M | ||
| Q4 24 | $46.4M | $7.2M | ||
| Q3 24 | $17.0M | $7.2M | ||
| Q2 24 | $17.8M | $9.8M | ||
| Q1 24 | $17.3M | $11.5M |
负债/权益比IVFPRSO
| Q4 25 | — | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 1.83× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.8M | $-1.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -101.6% | — |
| 资本支出强度资本支出/营收 | 0.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-7.8M | — |
8季度趋势，按日历期对齐
经营现金流IVFPRSO
| Q4 25 | — | $-1.1M | ||
| Q3 25 | $-1.8M | $-1.5M | ||
| Q2 25 | $-1.7M | $-2.0M | ||
| Q1 25 | $-3.5M | $-966.0K | ||
| Q4 24 | $-617.4K | $-687.0K | ||
| Q3 24 | $-640.8K | $-683.0K | ||
| Q2 24 | $-1.5M | $-659.0K | ||
| Q1 24 | $-260.6K | $-2.5M |
自由现金流IVFPRSO
| Q4 25 | — | — | ||
| Q3 25 | $-1.8M | $-1.6M | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $-696.3K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-310.3K | — |
自由现金流率IVFPRSO
| Q4 25 | — | — | ||
| Q3 25 | -101.6% | -48.9% | ||
| Q2 25 | -92.6% | — | ||
| Q1 25 | -216.9% | — | ||
| Q4 24 | -40.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -82.3% | — | ||
| Q1 24 | -19.7% | — |
资本支出强度IVFPRSO
| Q4 25 | — | — | ||
| Q3 25 | 0.5% | 1.1% | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 3.2% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IVF
暂无分部数据
PRSO
| Products | $2.8M | 96% |
| Other | $105.0K | 4% |
